NCT06456892View on ClinicalTrials.gov

Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

June 6, 2026

Study Completion Date

December 6, 2026

Conditions
RhabdomyosarcomaPediatric Cancer
Interventions
DRUG

Pucotenlimab

Pucotenlimab Combined with Standard Chemotherapy Regimen

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER